Healthcare Sales & Marketing Network News: Adenoscan

Searching News Database: Adenoscan

HSMN NewsFeed - 16 Mar 2009
Astellas to Terminate Offer for CV Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Feb 2009
Astellas Commences Tender Offer to Acquire All Outstanding Shares of CV Therapeutics for $16.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Feb 2009
Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Jan 2009
Astellas Proposes to Acquire CV Therapeutics for $16 per Share in Cash
Biopharmaceuticals Cardiology Mergers & Acquisitions

HSMN NewsFeed - 24 Jun 2008
Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI)
Biopharmaceuticals Radiology Cardiology

HSMN NewsFeed - 22 Oct 2007
Adenoscan(R) Patent Lawsuits Settled
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 Jun 2007
Indevus Appoints Industry Veteran Kurt Lewis as Senior Vice President Sales & Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2007
CV Therapeutics Submits New Drug Application For Regadenoson
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 4 Dec 2006
Regadenoson Meets Primary Endpoint in Second Phase 3 Clinical Trial
Biopharmaceuticals Cardiology

Return to NewsFeed

Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 9 additional stories matching:
Adenoscan
(Password required)

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!